157 research outputs found
Contaminant source localization via Bayesian global optimization
Contaminant source localization problems require efficient and
robust methods that can account for geological heterogeneities and accommodate
relatively small data sets of noisy observations. As realism commands
hi-fidelity simulations, computation costs call for global optimization
algorithms under parsimonious evaluation budgets. Bayesian optimization
approaches are well adapted to such settings as they allow the exploration of
parameter spaces in a principled way so as to iteratively locate the point(s)
of global optimum while maintaining an approximation of the objective
function with an instrumental quantification of prediction uncertainty. Here,
we adapt a Bayesian optimization approach to localize a contaminant source in
a discretized spatial domain. We thus demonstrate the potential of such a
method for hydrogeological applications and also provide test cases for the
optimization community. The localization problem is illustrated for cases
where the geology is assumed to be perfectly known. Two 2-D synthetic cases
that display sharp hydraulic conductivity contrasts and specific connectivity
patterns are investigated. These cases generate highly nonlinear objective
functions that present multiple local minima. A derivative-free global
optimization algorithm relying on a Gaussian process model and on the
expected improvement criterion is used to efficiently localize the point of
minimum of the objective functions, which corresponds to the contaminant
source location. Even though concentration measurements contain a significant
level of proportional noise, the algorithm efficiently localizes the
contaminant source location. The variations of the objective function are
essentially driven by the geology, followed by the design of the monitoring
well network. The data and scripts used to generate objective functions are
shared to favor reproducible research. This contribution is important
because the functions present multiple local minima and are inspired from a
practical field application. Sharing these complex objective functions
provides a source of test cases for global optimization benchmarks and should
help with designing new and efficient methods to solve this type of problem.</p
The Role of IRE1α in the Degradation of Insulin mRNA in Pancreatic β-Cells
The endoplasmic reticulum (ER) is a cellular compartment for the biosynthesis and folding of newly synthesized secretory proteins such as insulin. Perturbations to ER homeostasis cause ER stress and subsequently activate cell signaling pathways, collectively known as the Unfolded Protein Response (UPR). IRE1α is a central component of the UPR. In pancreatic β-cells, IRE1α also functions in the regulation of insulin biosynthesis.Here we report that hyperactivation of IRE1α caused by chronic high glucose treatment or IRE1α overexpression leads to insulin mRNA degradation in pancreatic β-cells. Inhibition of IRE1α signaling using its dominant negative form prevents insulin mRNA degradation. Islets from mice heterozygous for IRE1α retain expression of more insulin mRNA after chronic high glucose treatment than do their wild-type littermates.These results reveal a role of IRE1α in insulin mRNA expression under ER stress conditions caused by chronic high glucose. The rapid degradation of insulin mRNA could provide immediate relief for the ER and free up the translocation machinery. Thus, this mechanism would preserve ER homeostasis and help ensure that the insulin already inside the ER can be properly folded and secreted. This adaptation may be crucial for the maintenance of β-cell homeostasis and may explain why the β-cells of type 2 diabetic patients with chronic hyperglycemia stop producing insulin in the absence of apoptosis. This mechanism may also be involved in suppression of the autoimmune type 1 diabetes by reducing the amount of misfolded insulin, which could be a source of “neo-autoantigens.
JunB Inhibits ER Stress and Apoptosis in Pancreatic Beta Cells
Cytokines contribute to pancreatic β-cell apoptosis in type 1 diabetes (T1D) by modulation of β-cell gene expression networks. The transcription factor Activator Protein-1 (AP-1) is a key regulator of inflammation and apoptosis. We presently evaluated the function of the AP-1 subunit JunB in cytokine-mediated β-cell dysfunction and death. The cytokines IL-1β+IFN-γ induced an early and transitory upregulation of JunB by NF-κB activation. Knockdown of JunB by RNA interference increased cytokine-mediated expression of inducible nitric oxide synthase (iNOS) and endoplasmic reticulum (ER) stress markers, leading to increased apoptosis in an insulin-producing cell line (INS-1E) and in purified rat primary β-cells. JunB knockdown β-cells and junB−/− fibroblasts were also more sensitive to the chemical ER stressor cyclopiazonic acid (CPA). Conversely, adenoviral-mediated overexpression of JunB diminished iNOS and ER markers expression and protected β-cells from cytokine-induced cell death. These findings demonstrate a novel and unexpected role for JunB as a regulator of defense mechanisms against cytokine- and ER stress-mediated apoptosis
Human skin penetration of a copper tripeptide in vitro as a function of skin layer
We study a set of 28 GRB light-curves detected between 15 December
2002 and 9 June 2003 by the anti-coincidence shield of the
spectrometer (SPI) of INTEGRAL. During this period it has detected
50 bursts, that have been confirmed by other instruments, with a
time resolution of 50 ms. First, we derive the basic
characteristics of the bursts: various duration measures, the
count peak flux and the count fluence. Second, a sub-sample of 11 bursts with 12 individual, well-separated pulses is studied. We
fit the pulse shape with a model by Kocevski et al. (2003)
and find that the pulses are quite self-similar in shape. There is
also a weak tendency for the pulses with steep power-law decays to
be more asymmetric. Third, the variability of the complex
light-curves is studied by analyzing their power-density-spectra
(PDS) and their RMS variability.
The averaged PDS, of the whole sample, is a power-law with index
of and a break between 1–2 Hz. Fourth, we also
discuss the background and noise levels. We found that the
background noise has a Gaussian distribution and its power is
independent of frequency, i.e., it is white noise. However, it
does not follow a Poisson statistic since on average the variance
is ~1.6 larger than the mean. We discuss our results in
context of the current theoretical picture in which GRBs are
created in an anisotropic, highly relativistic outflow from
collapsing massive stars. Finally, we note that the exact
behaviour of the instrument is not yet known and therefore the
above results should be treated as preliminary.
Human skin penetration of a copper tripeptide in vitro as a function of skin layer
Objective and designSkin retention and penetration by copper applied as glycyl-L-histidyl-L-lysine cuprate diacetate was evaluated in vitro in order to assess its potential for its transdermal delivery as an anti-inflammatory agent.Materials and methodsFlow-through diffusion cells with 1 cm(2) exposure area were used under infinite dose conditions. 0.68% aq. copper tripeptide as permeant was applied on isolated stratum corneum, heat-separated epidermis and dermatomed skin and receptor fluid collected over 48 h in 4 h intervals using inductively coupled plasma mass spectrometry to analyze for copper in tissues and receptor fluid.ResultsThe permeability coefficient of the compound through dermatomed skin was 2.43 ± 0.51 × 10(-4) cm/h; 136.2 ± 17.5 μg/cm(2) copper permeated 1 cm(2) of that tissue over 48 h, while 97 ± 6.6 μg/cm(2) were retained as depot.ConclusionsCopper as tripeptide was delivered in potentially therapeutically effective amounts for inflammatory disease
FDA Critical Path Initiatives: Opportunities for Generic Drug Development
FDA’s critical path initiative documents have focused on the challenges involved in the development of new drugs. Some of the focus areas identified apply equally to the production of generic drugs. However, there are scientific challenges unique to the development of generic drugs as well. In May 2007, FDA released a document “Critical Path Opportunities for Generic Drugs” that identified some of the specific challenges in the development of generic drugs. The key steps in generic product development are usually characterization of the reference product, design of a pharmaceutically equivalent and bioequivalent product, design of a consistent manufacturing process and conduct of the pivotal bioequivalence study. There are several areas of opportunity where scientific progress could accelerate the development and approval of generic products and expand the range of products for which generic versions are available, while maintaining high standards for quality, safety, and efficacy. These areas include the use of quality by design to develop bioequivalent products, more efficient bioequivalence methods for systemically acting drugs (expansion of BCS waivers, highly variable drugs), and development of new bioequivalence methods for locally acting drugs
In Vitro Phenotypic, Genomic and Proteomic Characterization of a Cytokine-Resistant Murine β-TC3 Cell Line
Type 1 diabetes mellitus (T1DM) is caused by the selective destruction of insulin-producing β-cells. This process is mediated by cells of the immune system through release of nitric oxide, free radicals and pro-inflammatory cytokines, which induce a complex network of intracellular signalling cascades, eventually affecting the expression of genes involved in β-cell survival
Glucose and Fatty Acids Synergize to Promote B-Cell Apoptosis through Activation of Glycogen Synthase Kinase 3β Independent of JNK Activation
The combination of elevated glucose and free-fatty acids (FFA), prevalent in diabetes, has been suggested to be a major contributor to pancreatic β-cell death. This study examines the synergistic effects of glucose and FFA on β-cell apoptosis and the molecular mechanisms involved. Mouse insulinoma cells and primary islets were treated with palmitate at increasing glucose and effects on apoptosis, endoplasmic reticulum (ER) stress and insulin receptor substrate (IRS) signaling were examined.Increasing glucose (5-25 mM) with palmitate (400 µM) had synergistic effects on apoptosis. Jun NH2-terminal kinase (JNK) activation peaked at the lowest glucose concentration, in contrast to a progressive reduction in IRS2 protein and impairment of insulin receptor substrate signaling. A synergistic effect was observed on activation of ER stress markers, along with recruitment of SREBP1 to the nucleus. These findings were confirmed in primary islets. The above effects associated with an increase in glycogen synthase kinase 3β (Gsk3β) activity and were reversed along with apoptosis by an adenovirus expressing a kinase dead Gsk3β.Glucose in the presence of FFA results in synergistic effects on ER stress, impaired insulin receptor substrate signaling and Gsk3β activation. The data support the importance of controlling both hyperglycemia and hyperlipidemia in the management of Type 2 diabetes, and identify pancreatic islet β-cell Gsk3β as a potential therapeutic target
- …